117 related articles for article (PubMed ID: 32513535)
1. Pidotimod enhanced the anti-growth effect of cisplatin on lung cancer in mice via promoting anti-tumor immune response.
Wu T; Cui J; Gao J; Zhou H; Li A; Guo W
Biochem Biophys Res Commun; 2020 Aug; 528(4):678-684. PubMed ID: 32513535
[TBL] [Abstract][Full Text] [Related]
2. Pidotimod promotes functional maturation of dendritic cells and displays adjuvant properties at the nasal mucosa level.
Giagulli C; Noerder M; Avolio M; Becker PD; Fiorentini S; Guzman CA; Caruso A
Int Immunopharmacol; 2009 Nov; 9(12):1366-73. PubMed ID: 19712757
[TBL] [Abstract][Full Text] [Related]
3. Pidotimod in allergic diseases.
Manti S; Parisi GF; Papale M; Leonardi S
Minerva Pediatr; 2020 Oct; 72(5):358-363. PubMed ID: 32731733
[TBL] [Abstract][Full Text] [Related]
4. Synergistic immunostimulating activity of pidotimod and red ginseng acidic polysaccharide against cyclophosphamide-induced immunosuppression.
Du XF; Jiang CZ; Wu CF; Won EK; Choung SY
Arch Pharm Res; 2008 Sep; 31(9):1153-9. PubMed ID: 18806958
[TBL] [Abstract][Full Text] [Related]
5. Pidotimod and Immunological Activation in Individuals Infected with HIV.
Ucciferri C; Falasca K; Reale M; Tamburro M; Auricchio A; Vignale F; Vecchiet J
Curr HIV Res; 2021; 19(3):260-268. PubMed ID: 33430735
[TBL] [Abstract][Full Text] [Related]
6. Pidotimod. A new biological response modifier. Introduction.
Maillard F
Arzneimittelforschung; 1994 Dec; 44(12A):1399-401. PubMed ID: 7857330
[No Abstract] [Full Text] [Related]
7. Pidotimod for the prevention of acute respiratory infections in healthy children entering into daycare: A double blind randomized placebo-controlled study.
Mameli C; Pasinato A; Picca M; Bedogni G; Pisanelli S; Zuccotti GV;
Pharmacol Res; 2015 Jul; 97():79-83. PubMed ID: 25931316
[TBL] [Abstract][Full Text] [Related]
8. Pidotimod: a reappraisal.
Riboldi P; Gerosa M; Meroni PL
Int J Immunopathol Pharmacol; 2009; 22(2):255-62. PubMed ID: 19505378
[TBL] [Abstract][Full Text] [Related]
9. Pidotimod may prevent recurrent respiratory infections in children.
Licari A; De Amici M; Nigrisoli S; Marseglia A; Caimmi S; Artusio L; Marseglia GL
Minerva Pediatr; 2014 Oct; 66(5):363-7. PubMed ID: 25253184
[TBL] [Abstract][Full Text] [Related]
10. Effects of Pidotimod on recurrent respiratory infections in children with Down syndrome: a retrospective Italian study.
Valentini D; Di Camillo C; Mirante N; Marcellini V; Carsetti R; Villani A
Ital J Pediatr; 2020 Mar; 46(1):31. PubMed ID: 32164747
[TBL] [Abstract][Full Text] [Related]
11. Synergistic immunostimulatory effect of pidotimod and red ginseng acidic polysaccharide on humoral immunity of immunosuppressed mice.
Du Xiao F; Jiang CZ; Wu CF; Won EK; Choung SY
Pharmazie; 2008 Dec; 63(12):904-8. PubMed ID: 19177908
[TBL] [Abstract][Full Text] [Related]
12. Immunological hallmarks of cis-DDP-resistant Lewis lung carcinoma cells.
Fedorchuk O; Susak Y; Rudyk M; Senchylo N; Khranovska N; Skachkova O; Skivka L
Cancer Chemother Pharmacol; 2018 Feb; 81(2):373-385. PubMed ID: 29290023
[TBL] [Abstract][Full Text] [Related]
13. [Potentiation of the resistance to viral and bacterial infections after pidotimod administration in mice].
Marelli P; Lupetti A; Senesi S; Uslenghi C; Girardello R; Campa M
Drugs Exp Clin Res; 1993; 19 Suppl():15-21. PubMed ID: 8625778
[No Abstract] [Full Text] [Related]
14. [Stimulation of B-cell immunity in the nude mice by pidotimod: immunohistochemical stucy of various lymphoid organs].
Vacca A; Di Stefano R; Caloro D; Ranieri G; Dammacco F
Drugs Exp Clin Res; 1993; 19 Suppl():23-6. PubMed ID: 8625779
[No Abstract] [Full Text] [Related]
15. Carnosic acid enhances the anti-lung cancer effect of cisplatin by inhibiting myeloid-derived suppressor cells.
Liu W; Wu TC; Hong DM; Hu Y; Fan T; Guo WJ; Xu Q
Chin J Nat Med; 2018 Dec; 16(12):907-915. PubMed ID: 30595215
[TBL] [Abstract][Full Text] [Related]
16. Immunomodulatory activity of pidotimod administered with standard antibiotic therapy in children hospitalized for community-acquired pneumonia.
Esposito S; Garziano M; Rainone V; Trabattoni D; Biasin M; Senatore L; Marchisio P; Rossi M; Principi N; Clerici M
J Transl Med; 2015 Sep; 13():288. PubMed ID: 26335787
[TBL] [Abstract][Full Text] [Related]
17. Pidotimod exacerbates allergic pulmonary infection in an OVA mouse model of asthma.
Fu LQ; Li YL; Fu AK; Wu YP; Wang YY; Hu SL; Li WF
Mol Med Rep; 2017 Oct; 16(4):4151-4158. PubMed ID: 28731127
[TBL] [Abstract][Full Text] [Related]
18. Immunomodulating activity of Pidotimod in children with Down syndrome.
Zuccotti GV; Mameli C; Trabattoni D; Beretta S; Biasin M; Guazzarotti L; Clerici M
J Biol Regul Homeost Agents; 2013; 27(1):253-8. PubMed ID: 23489705
[TBL] [Abstract][Full Text] [Related]
19. Effects of pidotimod and bifidobacteria mixture on clinical symptoms and urinary metabolomic profile of children with recurrent respiratory infections: a randomized placebo-controlled trial.
Santamaria F; Montella S; Stocchero M; Pirillo P; Bozzetto S; Giordano G; Poeta M; Baraldi E
Pulm Pharmacol Ther; 2019 Oct; 58():101818. PubMed ID: 31302340
[TBL] [Abstract][Full Text] [Related]
20. Pidotimod, an immunostimulant in pediatric recurrent respiratory tract infections: A meta-analysis of randomized controlled trials.
Niu H; Wang R; Jia YT; Cai Y
Int Immunopharmacol; 2019 Feb; 67():35-45. PubMed ID: 30530167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
